Tatyana Feldman

Tatyana Feldman

UNVERIFIED PROFILE

Are you Tatyana Feldman?   Register this Author

Register author
Tatyana Feldman

Tatyana Feldman

Publications by authors named "Tatyana Feldman"

Are you Tatyana Feldman?   Register this Author

43Publications

1789Reads

33Profile Views

Contemporary management of nodal and primary splenic marginal zone lymphoma.

Expert Rev Hematol 2019 Oct 16. Epub 2019 Oct 16.

John Theurer Cancer Center , Hackensack , New Jersey , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2020.1681962DOI Listing
October 2019

Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.

Hematol Oncol 2019 Feb 23;37(1):35-38. Epub 2018 Oct 23.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2560
Publisher Site
http://dx.doi.org/10.1002/hon.2560DOI Listing
February 2019

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

N Engl J Med 2018 01 10;378(4):331-344. Epub 2017 Dec 10.

From the University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, Canada (J.M.C., K.J.S.); the Department of Hematology, Jagiellonian University, Krakow (W.J.), the Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw (E.L.-M.), the Department of Hematology and Transfusion Medicine, Center of Postgraduate Medical Education, Warsaw (E.L.-M.), the Department of Experimental Hematology, Medical University of Lodz, Lodz (P.S.), and the Department of Lymphoid Malignancy, the Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw (J.W.) - all in Poland; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (D.J.S., A.Y.); the Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN (S.M.A.); the Division of Hematology and Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea (W.S.K.); Research Innovation and Statistics, Antoine-Lacassagne Cancer Center, Nice, France (A.G.); Petrov Research Institute of Oncology, St. Petersburg, Russia (S.A.); the Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen (Á.I.), and the Department of Hematology, National Institute of Oncology, Budapest (A.R.) - both in Hungary; the Department of Advanced Biomedical Science, Federico II University Hospital, Naples (M.P.), and the Institute of Hematology Seràgnoli, University of Bologna, Bologna (P.L.Z.) - both in Italy; the Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston (Y.O.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (T.F.); the Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis (N.L.B.); the Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA (R.C.); the Department of Hematology-Oncology, Barbara Ann Karmanos Cancer Center, Detroit (R.R.); Gastrointestinal and Lymphoma Unit, The Royal Marsden NHS Foundation Trust, Sutton (D.C.), and the Department of Medical Oncology, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester (J.R.) - both in the United Kingdom; the Department of Clinical Development, Seattle Genetics, Bothell, WA (N.C.J., E.S.); and Oncology Clinical Research (J.S., H.A.J., D.H.) and Global Biostatistics (R.L.), Millennium Pharmaceuticals, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819601PMC
January 2018

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

J Clin Oncol 2017 Jun 14;35(16):1803-1813. Epub 2017 Mar 14.

James N. Kochenderfer, Robert P.T. Somerville, Tangying Lu, Victoria Shi, Stephanie L. Goff, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Udai S. Kammula, Constance M. Yuan, Mark J. Roschewski, Steven A. Feldman, Lori McIntyre, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD; Adrian Bot, John Rossi, Allen Xue, Marika Sherman, and Arianne Perez, Kite Pharma, Santa Monica, CA; Tatyana Feldman, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; and Jonathan W. Friedberg, University of Rochester School of Medicine, Rochester, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.3024
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.3024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455597PMC
June 2017

Treatment of Peripheral T-Cell Lymphoma in Community Settings.

Clin Lymphoma Myeloma Leuk 2017 06 10;17(6):354-361. Epub 2017 May 10.

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ; COTA Inc, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.05.001DOI Listing
June 2017

Targeting indolent non-Hodgkin lymphoma.

Expert Rev Hematol 2017 Apr 15;10(4):299-313. Epub 2017 Mar 15.

a Lymphoma Division , John Theurer Cancer Center , Hackensack , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1303374DOI Listing
April 2017

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.

Br J Haematol 2015 Aug 24;170(4):504-14. Epub 2015 Apr 24.

Center for Chronic Lymphocytic Leukemia and Lymphoma Program, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13463
Publisher Site
http://dx.doi.org/10.1111/bjh.13463DOI Listing
August 2015

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

J Clin Oncol 2015 Feb 25;33(6):540-9. Epub 2014 Aug 25.

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P.T. Somerville, Robert O. Carpenter, Maryalice Stetler-Stevenson, James C. Yang, Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute; Clara C. Chen, Clinical Center, National Institutes of Health (NIH); Sarah M. Kranick and Avindra Nath, National Institutes of Neurologic Disorders and Stroke, NIH, Bethesda, MD; Andre Goy and Tatyana Feldman, Hackensack University Medical Center, Hackensack, NJ; David E. Spaner, Sunybrook Odette Cancer Center, Toronto, Ontario, Canada; and Michael L. Wang, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.2025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322257PMC
February 2015

Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.

Leuk Lymphoma 2014 Dec 22;55(12):2932-4. Epub 2014 Apr 22.

John Theurer Cancer Center, Hackensack University Medical Center , Hackensack, NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.900760DOI Listing
December 2014

Osteomyelitis of the patella caused by Legionella anisa.

J Clin Microbiol 2013 Aug 12;51(8):2791-3. Epub 2013 Jun 12.

Microbiology and Molecular Pathology, Department of Pathology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.03190-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719613PMC
August 2013

Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedside.

Oncologist 2012 7;17(5):694-707. Epub 2012 May 7.

Lymphoma Division, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360909PMC
January 2013

Model of Abnormal Chromophore-Protein Interaction for Е181К Rhodopsin Mutation: Computer Molecular Dynamics Study.

Open Biochem J 2012 16;6:94-102. Epub 2012 Aug 16.

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, 4 ul. Kosygina, Moscow, 119334 Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874091X01206010094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428635PMC
August 2012

Liquid tumors in the elderly.

Clin Geriatr Med 2012 Feb;28(1):115-52

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cger.2011.12.002DOI Listing
February 2012